Literature DB >> 6324780

Fluorescence investigations of calmodulin hydrophobic sites.

A Follenius, D Gerard.   

Abstract

Calmodulin activation of target enzymes depends on the interaction between calmodulin hydrophobic regions and some enzyme areas. The Ca2+ induced exposure of calmodulin hydrophobic sites was studied by means of 2-p-toluidinylnaphthalene-6-sulfonate, a fluorescent probe. Scatchard and Job plots showed that the calmodulin-Ca42+ complex bound two molecules of this hydrophobic probe, with KD congruent to 1.4 X 10(-4) M. These sites are not totally exposed until calmodulin has bound four Ca2+ per molecule, so the conformational change is not over before the four specific Ca2+ - binding sites are saturated with Ca2+.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324780     DOI: 10.1016/0006-291x(84)90896-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Enhancement by Mg2+ of domain specificity in Ca2+-dependent interactions of calmodulin with target sequences.

Authors:  S R Martin; L Masino; P M Bayley
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

2.  X-ray structures of magnesium and manganese complexes with the N-terminal domain of calmodulin: insights into the mechanism and specificity of metal ion binding to an EF-hand.

Authors:  F Timur Senguen; Zenon Grabarek
Journal:  Biochemistry       Date:  2012-07-27       Impact factor: 3.162

Review 3.  Insights into modulation of calcium signaling by magnesium in calmodulin, troponin C and related EF-hand proteins.

Authors:  Zenon Grabarek
Journal:  Biochim Biophys Acta       Date:  2011-01-22

4.  Retinoic acid inhibits calmodulin binding to human erythrocyte membranes and reduces membrane Ca2(+)-adenosine triphosphatase activity.

Authors:  F B Davis; T J Smith; M R Deziel; P J Davis; S D Blas
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

5.  Amiodarone is a potent calmodulin antagonist.

Authors:  P Nokin; J P Blondiaux; P Schaeffer; L Jungbluth; C Lugnier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

6.  Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery.

Authors:  O Pauvert; C Lugnier; T Keravis; R Marthan; E Rousseau; J P Savineau
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

7.  The interaction of troponin C with phosphofructokinase. Comparison with calmodulin.

Authors:  J Q Lan; R F Steiner
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

8.  Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor.

Authors:  Thérèse Keravis; Fanny Monneaux; Issaka Yougbaré; Lucien Gazi; Jean-Jacques Bourguignon; Sylviane Muller; Claire Lugnier
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

9.  Low temperature aqueous electrospray ionization mass spectrometry of noncovalent complexes.

Authors:  T D Veenstra; A J Tomlinson; L Benson; R Kumar; S Naylor
Journal:  J Am Soc Mass Spectrom       Date:  1998-06       Impact factor: 3.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.